NEW YORK (GenomeWeb) – EKF Diagnostics recently announced that its board of directors has initiated a strategic review, to be led by an independent committee of non-executive directors consisting of Adam Reynolds, David Toohey, Doris Ann Williams, and chaired by Kevin Wilson.

The review was initiated at the suggestion of shareholders and is being done to explore all strategic options available to ensure shareholder value, a spokesperson for the firm told GenomeWeb in an email.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.